Donation Account: IBAN AT656000000510045254, BIC BAWAATWW, EB-CLINET, DEBRA International, Am Heumarkt 27/1, 1030 Vienna

donate now

1st Conference of EB-CLINET - Clinical Network of EB Centres and Experts

October 5-7, 2012
Salzburg, Austria

EB-CLINET Conference Video

Conference Report
A short report gives you the most important information about the contents and the outcomes of the conference.

Here you can find all presentations which are available for download.

Impressions from the Conference
Here you can find some picutures taken during the conference and the social events. If you might have further picutres you'd like to share with the other conference participants, please don't hesitate to send an email to webmaster(at)

Comments about the 1st Conference of EB-CLINET
Here you can find some comments we have received from participants of the EB-CLINET Conference. Thanks to all of you for your lovely and motivating words!

General Hospital Salzburg
Lecture Hall Medicine II
Muellner Hauptstrasse 48
5020 Salzburg

Final Programme - Download

Useful Information: See a map of the EB-CLINET conference venue and hotels by clicking here.

Please find useful information about Salzburg by clicking here.

Most of the EB-CLINET partners will meet at the 1st EB-CLINET Conference to be held in Salzburg from October 5-7, 2012. First they will be given the opportunity to present the situations in their respective countries. Then, important concerns and issues regarding future cooperation within the EB-CLINET network will be dealt with in various workshops. Reports on current EB research and the presentation of an international initiative for the training of EB specialists are also on the agenda. Moreover, the latest developments towards so-called "Best Practice Guidelines" for treating EB will be discussed, and practical tools, such as a general handbook for EB patients and a special book on occupational therapy for EB patients, will be presented. At the end of the conference, the participants will agree on the next steps to be taken and the strategies to be pursued for the future of EB-CLINET.


Flen Pharma